MINNEAPOLIS–(BUSINESS WIRE)–GT Metabolic™ Solutions, Inc. (“the Company” or “GT Metabolic”), a pioneer in the medical device field and the first to receive FDA De Novo grant and 510(k) clearance for use of magnetic technology to create compression anastomoses (connections between two tubular structures in the body, such as intestines), today announced a Series C growth investment from J.P. Morgan Life Sciences Private Capital. Proceeds from the financing will support the Company’s ongoing glo
